McKesson Corporation (MCK)
$783.39+2.56%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Dominant drug distributor growing earnings fast via oncology and buybacks; CVS concentration is the key risk.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes bran…
- Sector:
- Healthcare
- Industry:
- Medical Distribution
- Market Cap:
- $94.2B
Recent dividends
- 1 Jun 2026$0.82
- 2 Mar 2026$0.82
- 1 Dec 2025$0.82
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across McKesson Corporation and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free